# Response of Clostridium Difficile Infection to Metronidazole Therapy

> **NCT00304369** · — · COMPLETED · sponsor: **Michael E. DeBakey VA Medical Center** · enrollment: 290 (estimated)

## Conditions studied

- Clostridium Enterocolitis
- Pseudomembranous Colitis
- Antibiotic-Associated Colitis

## Interventions

- **DRUG:** Metronidazole

## Key facts

- **NCT ID:** NCT00304369
- **Lead sponsor:** Michael E. DeBakey VA Medical Center
- **Sponsor class:** FED
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 290 (ESTIMATED)
- **Last updated:** 2013-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00304369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00304369, "Response of Clostridium Difficile Infection to Metronidazole Therapy". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00304369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*